Answers are grounded in this paper and cite their sources.
Mini-review highlights the multifunctional potential of amino acid-based surfactants in drug delivery and antimicrobial applications.
Amino acid-based gemini surfactants (AAGSs) represent a distinctive class of eco-friendly amphiphiles that combine low critical micelle concentrations, structural tunability, and versatile self-assembly with the inherent biocompatibility of natural amino acids. Their twin-head/twin-tail architecture enables efficient interactions with biological systems, supporting diverse biomedical functions. Recent studies highlight their ability to solubilize poorly water-soluble drugs, compact nucleic acids for non-viral gene delivery, and form reversible aggregates for stimuli-responsive release. Interactions with proteins such as serum albumins and enzymes further demonstrate their capacity to stabilize therapeutics while reducing cytotoxicity compared with conventional cationic surfactants. Arginine-, serine-, and cystine-derived AAGSs also display strong antimicrobial and antibiofilm activity, underscoring their multifunctional potential at biointerfaces. This mini-review summarizes advances in synthetic strategies, micellization behaviour, and protein–surfactant interactions of AAGSs, with emphasis on drug delivery, gene transfection, antimicrobial systems, and protein stabilization. Remaining challenges include establishing predictive structure-function relationships, evaluating long-term biocompatibility, and developing scalable synthetic routes. Overall, AAGSs offer a promising platform for next-generation surfactants with biomedical and environmental relevance.
No takes yet. Share an insight, caveat, or question.
Nirmal Singh (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: